Imricor Medical Systems, Inc. (IMR.AX)
Imricor Medical Systems, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Burnsville, MN, US. The stock last traded at $1.97, up 0.77% on the session, giving a market capitalisation of $630.7M. Its beta of 0.46 implies it has historically moved less than the broad market.
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc. is most often compared with the following Healthcare names: